Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
That’s been the question floating around ResMed's (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea ...
Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.
Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.
Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in ...
Orders accelerated, margins expanded, and cash flow held up despite tariffs and the long shadow of Respironics.
Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in comparable sales and a 160-basis-point improvement in adjusted EBITA margin to ...
Amsterdam, February 10, 2026Full year and Q4 highlightsComparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in ...
SINGAPORE: Total employment growth in Singapore was stronger in 2025 than it was in 2024, with unemployment and retrenchments remaining low and stable, according to advance labour market figures for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results